tickstock newsroom AI
Articles
Experian appoints Adam Crozier as chair designate
First Light Fusion secures £25m first close to accelerate FLARE development
Bango wins DCB contracts with Telin and LMT
Intercede secures c$3.8m in upsells and renewal from US and UK government customers
Intercede has received c$3.8m of orders for MyID CMS perpetual licences, support and maintenance, booked via partners.
Associated British Foods reports 18% profits drop, greenlights Primark split
Adjusted operating profit fell 18% in the 24 weeks to 28 February while revenue dipped 2%; the group kept its interim dividend, increased investment and confirmed a planned demerger of Primark.
British Land upgrades FY27 EPS guidance after leasing surge
British Land expects FY26 Underlying EPS of 28.9p, reports like‑for‑like net rental growth of 6% and has raised FY27 Underlying EPS guidance to at least 30.5p following strong campus and retail park leasing and the acquisition of Life Science REIT.
Accsys Technologies posts record Accoya volumes and says FY26 will be in line with consensus
Accsys expects FY26 adjusted EBITDA to match market consensus after a year of record sales—77,237m3—and like‑for‑like revenue growth of 20%.
CRISM Therapeutics shows 58% tumour reduction with Docetaxel-ChemoSeed
CRISM Therapeutics Corporation's Docetaxel-ChemoSeed cut tumour volume by up to 58% versus systemic docetaxel in a preclinical prostate cancer model, and showed a clear dose response with fewer tolerability issues.
Crest Nicholson cuts unit guidance and flags sharply lower land-sale revenue
Crest Nicholson narrows full-year volumes to 1,400–1,500 homes, now expects EBIT of about £5m–£15m and sees land-sale revenue of c. £40m as it prioritises cash and seeks temporary covenant relief.
IXICO reports 23% H1 revenue rise as order book expands to £18.1m
IXICO expects first-half revenue to climb 23% to £3.9m, with gross margin improving to 53% and an EBITDA loss narrowing to £0.5m, while the signed order book grows to £18.1m; interim results are due 19 May.
THG posts strongest Q1 revenue growth since 2021
THG said Group revenue rose 7.0% in the quarter to 31 March, led by Beauty and Nutrition, and reiterated full-year guidance.
Windar Photonics appoints Andreas Berg Nielsen as CEO
Windar Photonics has promoted Non‑Executive Director Andreas Berg Nielsen to chief executive officer, effective 1 June, tasking him with executing the group's growth strategy.
Norman Broadbent reiterates FY26 NFI growth after Q1 NFI falls to £2.2m
Norman Broadbent reported Q1 net fee income of £2.2m (Q1 25: £3m), said it added four fee earners and acquired Society, and reiterated that it expects NFI growth in FY26.
genedrive in line for NHS-wide MT‑RNR1 tender as England publishes premarket engagement
genedrive plc’s point‑of‑care MT‑RNR1 test is now explicitly scoped in NHS England’s market engagement notice, which signals a planned tender publication on 1 January 2027 and a go‑live target of 1 July 2027.
S&U posts £31.8m pre-tax profit as impairment charges fall and loan book expands
S&U delivered a 32% rise in pre-tax profit to £31.8m for the year ended 5 February, even as revenue slipped to £107.4m and net borrowings rose to £241.8m.
AstraZeneca's Ultomiris meets primary endpoint in IgAN Phase III
AstraZeneca said Ultomiris (ravulizumab) produced a statistically significant, clinically meaningful reduction in proteinuria at week 34 in the I CAN Phase III trial, with declines evident as early as week 10.
Valereum settles with Blubird and receives shares plus BLU tokens
Valereum has reached a confidential settlement with Blubird Global, taking 504,824 common shares (about 5.66% fully diluted) and 1.98m BLU tokens that will vest linearly over 24 months.
Supreme secures five-year UK licence to make and distribute Carabao drinks
Supreme has signed an exclusive five-year UK licensing agreement with Carabao to manufacture and distribute the energy and isotonic drinks brand across the UK.
Associated British Foods to demerge Primark from its Food business
ABF will separate Primark into a newly listed company, with the group aiming to complete a dividend demerger before the end of 2027 and shareholders receiving shares in both entities.